Reduced jaw opening from paradoxical activity of mandibular elevator muscles treated with botulinum toxin

European Journal of Neurology

Volumn 10, Issue 6, 2003, Pages 695-699

  Bakke, M ^a   Werdelin, L M ^b   Dalager, T ^b   Fuglsang Frederiksen, A ^c   Prytz, S ^b   Moller E ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Botulinum toxin; Electromyography; Jaw opening; Masticatory muscles; Oromandibular dystonia; Paradoxical activity

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BRAIN STEM INJURY; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DYSPHAGIA; DYSTONIA; ELECTROMYOGRAM; FEMALE; HUMAN; JAW MUSCLE; LOW DRUG DOSE; MALE; MANDIBLE; MASTICATION; MEDICAL ASSESSMENT; MUSCLE INNERVATION; NERVE BLOCK; OROMANDIBULAR DYSTONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; TRISMUS;

AGED; BOTULINUM TOXIN TYPE A; ELECTROMYOGRAPHY; FEMALE; HUMANS; JAW DISEASES; MALE; MASTICATORY MUSCLES; MIDDLE AGED; MOVEMENT; NEUROMUSCULAR AGENTS;

EID: 0346334485     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00664.x     Document Type: Article

References (25)

1. Ajax T, Ross MA, Rodnitzsky RL (1998). The role of electromyography in guiding botulinum toxin injections for focal dystonia and spasticity. J Neurol Rehabil 12:1-4.
2. Bakke M, Møller E, Rasmussen OC (1980). Effect of intramuscular local anaesthetics on maximal voluntary activity in human anterior temporal muscles. Arch Oral Biol 25:121-125.
3. Bakke M, Holm B, Jensen BL, Michler L, Møller E (1990). Unilateral, isometric bite force in 8-68-year-old women and men related to occlusal factors. Scand J Dent Res 98:149-158.
4. van der Bergh P, Kollmann P (1995). Five-year experience in the treatment of focal movement disorders with low-dose Dysport™ botulinum toxin. Muscle Nerve 18:720-729.
5. Brin MF (1997). Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve 20: 146-168.
6. Brin MF (2000). Botulinum toxin therapy: basic science and overview of other therapeutic applications. In: Blitser A, ed. Management of Facial Lines and Wrinkles. Williams and Wilkens, Philadelphia, Lippincott, pp. 279-302.
7. Capra NF, Bernanke JM, Porter JD (1991). Ultrastructural changes in the masseter muscle of macaca fascicularis resulting from intramuscular injections of botulinum toxin type A. Arch Oral Biol 36:827-836.
8. Cody FWJ, Lee RWH, Taylor A (1972). A functional analysis of the components of the mesencephalic nucleus of the fifth nerve in the cat. J Physiol 226:249-261.
9. Eriksson PO, Thornell LE (1983). Histochemical and morphological muscle-fibre characteristics of the human masseter, the medial pterygoid and the temporal muscles. Arch Oral Biol 28:781-795.
10. Goodwin GM, Luschei ES (1974). Discharge of spindle afferents from jaw-closing muscles during chewing in alert monkeys. J Neurophysiol 38:560-571.
11. Goto TH, Langenbach GE, Hannam AG (2001). Length changes in the human masseter after jaw movement. Anatomical Rec 262:293-300.
12. Hamjian JA, Walker FO (1994). Serial neurophysiological studies of intramuscular botulinum-A toxin in humans. Muscle Nerve 17:1385-1392.
13. Jelasic F, Freitag V (1978). Inverse activity of masticatory muscles with and without trismus: a brainstem syndrome. J Neurol Neurosurg Psychiatry 41:798-804.
14. Lagueny L, Delian MM, Julien J, Demotes-Mainard J, Ferrer X (1989). Jaw closing spasm - a form of focal dystonia? An electrophysiological study. J Neurol Neurosurg Psychiatry 52:652-655.
15. Møller E (1966). The chewing apparatus. An electromyographic study of the action of the muscles of mastication and its correlation to facial morphology. Acta Physiol Scand 69(Suppl. 280):1-229.
16. McAllister RMR, Calder JS (1995). Paradoxical clinical consequences of peripheral nerve injury: a review of anatomical, neurophysiological and psychological mechanisms. Br J Plastic Surg 48:384-395.
17. Naumann M, Dauphin M, Reichmann H, Reiners KH (1995). Botulinum toxin in the management of paradoxical activity of jaw muscles (letter to the editor). J Neurol Neurosurg Psychiatry 59:192-193.
18. Ongeborer de Visser BW (1983). Anatomical and functional organization of reflexes involving the trigeminal system in man: jaw reflex, blink reflex, corneal reflex and exteroceptive suppression. Adv Neurol 39:727-738.
19. Orchardson R, Cadden SW (1998). Mastication. In: Linden RWA, ed. Frontiers of Oral Biology. Vol. 9. The Scientific Basis of Eating. Taste and Smell. Salivation, Mastication and Swallowing and their Dysfunctions. Karger, Basel, pp. 76-121.
20. Østergaard L, Fuglsang-Frederiksen A, Sjö O, Werdelin L, Winkel H (1996). Quantitative EMG in cervical dystonia. Electromyogr Clin Neurophysiol 36:179-185.
21. Rosales RL, Arimura K, Takenaga S, Osame M (1996). Extrafusal and intrafusal muscle effects on experimental botulinum toxin-A injection. Muscle Nerve 19:488-498.
22. Sankhla C, Lai EC, Jankovic J (1998). Peripherally induced oromandibular dystonia. J Neurol Neurosurg Psychiatry 65:722-728.
23. Schwerdtfeger K, Jelasic F (1985). Trismus in postoperative, posttraumatic and other brain stem lesions caused by paradoxical activity of masticatory muscles. Acta Neurochirurgica 76:62-66.
24. Scutter SD, Turker KS (2001). The role of the muscle spindles in human masseter. Human Movement Sci 20:489-497.
25. Tan EK, Jankovic J (1999). Botulinum toxin A in patients with oromandibular dystonia. Neurology 53:2102-2107.